Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac
- PMID: 1650784
- DOI: 10.1016/0166-0934(91)90161-r
Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac
Abstract
Defective herpes simplex virus type 1 (HSV-1) vectors can deliver genes into both mitotic and postmitotic cells, including neurons and these vectors, therefore, have great potential use. pHSVlac, the prototype HSV-1 vector, expresses the E. coli Lac Z gene from the HSV-1 immediate early 4/5 promoter. pHSVlac can stably express beta-galactosidase in a range of mammalian cell lines and in neurons from throughout the nervous system, both in culture and in the adult rat brain. Thus, HSV-1 vectors may be useful for studying HSV-1 latency, neuronal physiology, and performing gene therapy for neurological conditions. A virus stock of pHSVlac consists of identical HSV-1 particles containing either pHSVlac DNA or the HSV-1 helper virus DNA. Thus, a cell can be infected with the pHSVlac virus, the helper virus, or both; consequently, it is important to determine if the helper virus influences the behavior of pHSVlac. The effect of the helper virus on expression of beta-galactosidase from pHSVlac was investigated: it was demonstrated first, that pHSVlac can be efficiently packaged into HSV-1 virus particles using each of five HSV-1 temperature sensitive (ts) mutants as helper virus. Second, pHSVlac grown with each of the five HSV-1 ts mutants expressed high levels of beta-galactosidase. Third, pHSVlac grown with HSV-1 strain 17 ts K as helper virus expresses the same amount of beta-galactosidase in the absence or presence of ts K. Thus, pHSVlac can efficiently express a gene independent of the HSV-1 helper virus.
Similar articles
-
Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.Biotechniques. 1996 Mar;20(3):460-9. doi: 10.2144/19962003460. Biotechniques. 1996. PMID: 8679207
-
A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters.J Neurosci Methods. 1991 Jan;36(1):91-103. doi: 10.1016/0165-0270(91)90142-m. J Neurosci Methods. 1991. PMID: 1648153
-
An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.Proc Natl Acad Sci U S A. 1990 Nov;87(22):8950-4. doi: 10.1073/pnas.87.22.8950. Proc Natl Acad Sci U S A. 1990. PMID: 2174168 Free PMC article.
-
Herpesviruses: expression of genes in postmitotic brain cells.Curr Opin Genet Dev. 1993 Feb;3(1):81-5. doi: 10.1016/s0959-437x(05)80345-4. Curr Opin Genet Dev. 1993. PMID: 8384036 Review.
-
Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.Exp Neurol. 1997 Mar;144(1):98-102. doi: 10.1006/exnr.1996.6394. Exp Neurol. 1997. PMID: 9126158 Review.
Cited by
-
An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells.J Neurochem. 1995 Feb;64(2):487-96. doi: 10.1046/j.1471-4159.1995.64020487.x. J Neurochem. 1995. PMID: 7830040 Free PMC article.
-
Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.Nucleic Acids Res. 1991 Dec;19(25):7219-23. doi: 10.1093/nar/19.25.7219. Nucleic Acids Res. 1991. PMID: 1662813 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources